Abstract
The introduction of pre-exposure prophylaxis (PrEP) for HIV has triggered critical analysis within the social sciences. For example, some have signalled how PrEP may lead to a renewed medicalisation of gay and other homosexually-active men’s sexuality. This chapter challenges some of those accounts. Adopting a public health ethics perspective, it argues that gay men should be understood as agentic in their use of PrEP, as opposed to being the passive victims of medicalisation, and that greater attention should be paid to questions of pleasure in PrEP use. Applying a reproductive justice framework, the chapter argues that the worldwide inaccessibility of PrEP constitutes a more serious ethical issue than the potential problem of the medicalisation of gay men’s sexuality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The main ethical principles within this safe sex ethics framework are respect for autonomy and justice (Brisson et al. 2019b, pp. 54–55): respect for autonomy by acknowledging the right to engage in sex and to choose preventive measures; and respect for justice by paying attention to social context, in this case how the HIV epidemic principally affects already socially marginalised communities, hence creating the need to address issues related to justice.
References
Aggleton, P., & Parker, R. (2015). Moving beyond biomedicalization in the HIV response: Implications for community involvement and community leadership among men who have sex with men and transgender people. American Journal of Public Health, 105(8), 1552–1558.
Bekker, L. G., Alleyne, G., Baral, S., Cepeda, J., Daskalakis, D., Dowdy, D., et al. (2018). Advancing global health and strengthening the HIV response in the era of the sustainable development goals: The international AIDS society—Lancet commission. The Lancet, 392(10144), 312–358.
Berkowitz, R. (2003). Stayin’ alive: The invention of safe sex, a personal history. Boulder: Westview.
Brisson, J., Ravitsky, V., & Williams-Jones, B. (2019a). Informal PrEP: An emerging need for nomenclature. The Lancet Public Health, 4(2), e83.
Brisson, J., Ravitsky, V., & Williams-Jones, B. (2019b). Towards an integration of PrEP into a safe sex ethics framework for men who have sex with men. Public Health Ethics, 12(1), 54–63.
Calabrese, S. K., & Underhill, K. (2015). How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: A call to destigmatize “Truvada whores”. American Journal of Public Health, 105(10), 1960–1964.
Campbell, C., Skovdal, M., & Gibbs, A. (2011). Creating social spaces to tackle AIDS-related stigma: Reviewing the role of church groups in sub-Saharan Africa. AIDS & Behavior, 15(6), 1204–1219.
Clarke, A. E., Fishman, J. R., Fosket, J. R., Mamo, L., & Shim, J. K. (2000). Technoscience and the new biomedicalization: Western roots, global rhizomes. Sciences Sociales et Santé, 18(2), 11–42.
Collin, J., & David, P. M. (2016). Vers une pharmaceuticalisation de la société: le médicament comme objet social. Québec: Presses de l’Université du Québec.
Conrad, P. (1992). Medicalization and social control. Annual Review of Sociology, 18, 209–232.
Dean, T. (2015). Mediated intimacies: Raw sex, Truvada, and the biopolitics of chemoprophylaxis. Sexualities, 18(1–2), 224–246.
Elopre, L., Kudroff, K., Westfall, A. O., Overton, E. T., & Mugavero, M. J. (2017). The right people, right places, and right practices: Disparities in PrEP access among African American men, women and MSM in the deep south. Journal of Acquired Immune Deficiency Syndromes (1999), 74(1), 56–59.
Feinberg, J. (2012). Truvada PrEP: Why I voted “yes”. Annals of Internal Medicine, 157(7), 521–522.
Giami, A., & Perrey, C. (2012). Transformations in the medicalization of sex: HIV prevention between discipline and biopolitics. Journal of Sex Research, 49(4), 353–361.
Girard, G. (2016). “La pilule qui change tout?”: Analyses des débats québécois autour de la prophylaxie préexposition du VIH. In J. Collin & P. M. David (Eds.), Vers une pharmaceuticalisation de la société: le médicament comme objet social (pp. 193–222). Québec: Presses de l’Université du Québec.
Girard, G., Patten, S., LeBlanc, M. A., Adam, B. D., & Jackson, E. (2019). Is HIV prevention creating new biosocialities among gay men? Treatment as prevention and pre-exposure prophylaxis in Canada. Sociology of Health & Illness, 41(3), 484–501.
Gitome, S., Njuguna, S., Kwena, Z., Ombati, E., Njoroge, B., & Bukusi, E. A. (2014). Perspective paper: Medicalization of HIV and the African response. African Journal of Reproductive Health, 18(3), 25–33.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., et al. (2010). Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New England Journal of Medicine, 363(27), 2587–2599.
Hayes, R., Schmidt, A. J., Pharris, A., Azad, Y., Brown, A. E., Weatherburn, P., et al. (2019). Estimating the ‘PrEP gap’: How implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Eurosurveillance, 24(41), 1900598.
Junge, B. (2002). Bareback sex, risk, and eroticism: Anthropological themes (re)surfacing in the post-AIDS era. In E. Lewin & W. L. Leap (Eds.), Out in theory the emergence of gay and lesbian anthropology (pp. 186–221). Urbana & Chicago: University of Illinois Press.
Kowalewski, M. R. (1990). Religious constructions of the AIDS crisis. Sociological Analysis, 51(1), 91–96.
Lancet, H. I. V. (2019a). Are 2 million bottles of PrEP an empty gesture? The Lancet HIV, 6(8), PE483.
Lancet, H. I. V. (2019b). New PrEP formulation approved… but only for some. The Lancet HIV, 6(11), e723.
Lau, R. K. W., Jenkins, P., Caun, K., Forster, S. M., Weber, J. N., McManus, T. J., et al. (1992). Trends in sexual behaviour in a cohort of homosexual men: A 7-year prospective study. International Journal of STD & AIDS, 3(4), 267–272.
Lock, M. (2001). The tempering of medical anthropology: Troubling natural categories. Medical Anthropology Quarterly, 15(4), 478–492.
Luna, Z., & Luker, K. (2013). Reproductive justice. Annual Review of Law and Social Science, 9, 327–352.
Mabire, X., Puppo, C., Morel, S., Mora, M., Rojas Castro, D., Chas, J., et al. (2019). Pleasure and PrEP: Pleasure-seeking plays a role in prevention choices and could Lead to PrEP initiation. American Journal of Men’s Health, 13(1), 1557988319827396.
Mansergh, G., Koblin, B. A., & Sullivan, P. S. (2012). Challenges for HIV pre-exposure prophylaxis among men who have sex with men in the United States. PLoS Medicine, 9(8), e1001286.
McManus, F., & Mercado-Reyes, A. (2016). Constructing publics, preventing diseases and medicalizing bodies: HIV, AIDS, and its visual cultures. Sexualidad, Salud y Sociedad, 24, 69–102.
McDavitt, B., & Mutchler, M. G. (2014). “Dude, you’re such a slut!” barriers and facilitators of sexual communication among young gay men and their best friends. Journal of Adolescent Research, 29(4), 464–498.
Page, K. R., Martinez, O., Nieves-Lugo, K., Zea, M. C., Grieb, S. D., Yamanis, T. J., et al. (2017). Promoting pre-exposure prophylaxis to prevent HIV infections among sexual and gender minority Hispanics/Latinxs. AIDS Education & Prevention, 29(5), 389–400.
Pawson, M., & Grov, C. (2018). ‘It’s just an excuse to slut around’: Gay and bisexual mens’ constructions of HIV pre-exposure prophylaxis (Pr EP) as a social problem. Sociology of Health & Illness, 40(8), 1391–1403.
Preciado, B. (2013). Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era, (B. Benderson, Trans.). New York: Feminist Press.
Preciado, P. (2015, June 11). Condoms chimiques. Libération. https://www.liberation.fr/chroniques/2015/06/11/condoms-chimiques_1327747
Race, K. D. (2003). Revaluation of risk among gay men. AIDS Education & Prevention, 15(4), 369–381.
Race, K. (2009). Pleasure consuming medicine: The queer politics of drugs. Durham, NC: Duke University Press.
Rose, N. (2007). Beyond medicalization. The Lancet, 369(9562), 700–702.
Ross, L., & Solinger, R. (2017). Reproductive justice: An introduction. Oakland: University of California Press.
Schubert, K. (2019). The democratic biopolitics of PrEP. In H. Gerhards & K. Braun (Eds.), Biopolitiken–Regierungen des Lebens heute (pp. 121–153). Wiesbaden: Springer VS.
Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Global Public Health, 11(7–8), 1060–1075.
Smith, A. (2005). Beyond pro-choice versus pro-life: Women of colour and reproductive justice. The National Women’s Studies Association Journal, 17(1), 119–140.
Spieldenner, A. (2016). PrEP whores and HIV prevention: The queer communication of HIV pre-exposure prophylaxis (PrEP). Journal of Homosexuality, 63(12), 1685–1697.
Syvertsen, J. L., Bazzi, A. M. R., Scheibe, A., Adebajo, S., Strathdee, S. A., & Wechsberg, W. M. (2014). The promise and peril of pre-exposure prophylaxis (PrEP): Using social science to inform prep interventions among female sex workers. African Journal of Reproductive Health, 18(3), 74–83.
Thomann, M. (2018). On December 1, 2015, sex changes. Forever’: Pre-exposure prophylaxis and the pharmaceuticalisation of the neoliberal sexual subject. Global Public Health, 13(8), 997–1006.
UN. (2017). Ending AIDS. Progress towards the 90-90-90 targets. Geneva: Joint United Nations Programme on HIV/AIDS.
Wells, S. (2017). Feminism, false consciousness, & consent: A third way. Georgetown Journal of Gender and the Law, 18(1), 251.
Williams, S. J., Martin, P., & Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health & Illness, 33(5), 710–725.
Wood, L. V. (2012). Why I voted “no” to Truvada PrEP. Annals of Internal Medicine, 157(7), 519–520.
Young, I., Flowers, P., & McDaid, L. (2016). Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention. Sociology of Health & Illness, 38(3), 411–425.
Zola, I. K. (1972). Medicine as an institution of social control. The Sociological Review, 20(4), 487–504.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
This work was supported by a doctoral research award to Julien Brisson from the Canadian Institutes of Health Research [grant number 201610GSD-385545-283387] in honour of Nelson Mandela.
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Brisson, J., Ravitsky, V., Williams-Jones, B. (2021). Agency, Pleasure and Justice: A Public Health Ethics Perspective on the Use of PrEP by Gay and Other Homosexually-Active Men. In: Bernays, S., Bourne, A., Kippax, S., Aggleton, P., Parker, R. (eds) Remaking HIV Prevention in the 21st Century. Social Aspects of HIV, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-69819-5_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-69819-5_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-69818-8
Online ISBN: 978-3-030-69819-5
eBook Packages: Social SciencesSocial Sciences (R0)